• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

the@unimelb.edu.au

Credentials


Position
Honorary (Fellow)
The Sir Peter MacCallum Department of Oncology
ORCID

0000-0001-5206-5111

Dr Ella Thompson

Honorary (Fellow)
The Sir Peter MacCallum Department of Oncology

114 Scholarly works
0 Projects

HIGHLIGHTS

  • 2023

    Journal article

    Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia
    DOI: 10.1182/blood.2022016090
  • 2022

    Journal article

    Enrichment of BTK Leu528Trp mutations in patients with CLL on zanubrutinib: potential for pirtobrutinib cross-resistance
    DOI: 10.1182/bloodadvances.2022008325
  • 2022

    Journal article

    Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLL
    DOI: 10.1182/blood.2021012775
  • 2021

    Journal article

    Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition
    DOI: 10.1182/bloodadvances.2021005083
  • 2020

    Journal article

    BAX-Mutated Clonal Hematopoiesis in Patients on Long-Term Venetoclax for Relapsed/Refractory Chronic Lymphocytic Leukemia
    DOI: 10.1182/blood-2020-137775
  • 2020

    Journal article

    Multiple BCL2 mutations cooccurring with Gly101Val emerge in chronic lymphocytic leukemia progression on venetoclax
    DOI: 10.1182/BLOOD.2019004205
  • 2019

    Journal article

    Characterization of a novel venetoclax resistance mutation (BCL2 Phe104Ile) observed in follicular lymphoma
    DOI: 10.1111/bjh.16069
Ella Thompson

RECENT SCHOLARLY WORKS

  • 2026

    Journal article

    Advancing diagnostic targeted RNA sequencing for haematological malignancies within an Australian sample exchange program
    DOI: 10.1016/j.pathol.2025.09.003
  • 2026

    Journal article

    KRAS internal tandem duplications and alternative driver variants in BRAF Val600Glu negative hairy cell leukemia
    DOI: 10.1080/10428194.2026.2615055
  • 2025

    Journal article

    Landscape of TP53 abnormalities and IGHV mutational profile in untreated Australian patients with chronic lymphocytic leukaemia
    DOI: 10.1016/j.pathol.2025.06.013
  • 2025

    Journal article

    Integrative analysis of the tumour immune microenvironment of breast implant-associated anaplastic large cell lymphoma using multi-omics
    DOI: 10.1182/blood-2025-3563
  • 2025

    Journal article

    Genomic variation in DDX41 identified through clinical sequencing
    DOI: 10.1111/bjh.70086
  • 2025

    Journal article

    423 | ctDNA‐DIRECTED INTERVENTION WITH EPCORITAMAB ALONE OR IN COMBINATION WITH LENALIDOMIDE‐RITUXIMAB IS FEASIBLE IN THE EARLY POST‐CAR‐T POPULATION AT HIGH RISK OF RELAPSE
    DOI: 10.1002/hon.70094_423
  • 2025

    Journal article

    Oncogenic gene fusion detection by NGS in haematopathology: lessons from a national sample exchange program
    DOI: 10.1016/j.pathol.2024.12.114
  • 2025

    Journal article

    Using artificial intelligence (AI) to model clinical variant reporting for next generation sequencing (NGS) oncology assays
    DOI: 10.1186/s13040-025-00489-y

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224